About UsForte Biosciences, Inc.

Forte Biosciences is a biopharmaceutical company focused on autoimmune diseases. Forte’s lead product, FB-102, is a proprietary molecule for the treatment of autoimmune and autoimmune related diseases. Our initial focus will be on Graft-versus-Host Disease (GvHD), Vitiligo and Alopecia Areata, large indications with unmet needs. GvHD is a common potentially life-threatening complication commonly associated with allogeneic hematopoietic stem cell transplantation. Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color. Alopecia Areata is where patches of hair loss occur on the scalp or the body.

Learn More

Our ResearchPipeline

Forte is developing a potentially first-in-class biotherapeutic for the treatment of autoimmune diseases with FB-102 its lead product candidate.

Learn More